Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 7/20 | 0.68 |
| ▸ | NR1I3 | Q14994 | 1/20 | 0.51 |
| ▸ | NPC1 | O15118 | 5/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.49 |
| ▸ | TP53 | P04637 | 2/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.49 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.49 |
| ▸ | ENPP3 | O14638 | 1/20 | 0.49 |
| ▸ | IDO1 | P14902 | 1/20 | 0.48 |
| ▸ | METAP2 | P50579 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.48 |
| ▸ | ACHE | P22303 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | CASP3 | P42574 | 1/20 | 0.47 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.47 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4546968 | 0.98 | RAB9A (0.70) | RAB9ANR1I3NPC1SMN1; SMN2TP53 | |
| SCHEMBL3766697 | 0.95 | RAB9A (0.73) | RAB9ANR1I3NPC1SMN1; SMN2TP53 | |
| SCHEMBL17726137 | 0.94 | RAB9A (0.61) | RAB9ANR1I3NPC1SMN1; SMN2TP53 | |
| SCHEMBL4546941 | 0.94 | RAB9A (0.61) | RAB9ANR1I3NPC1SMN1; SMN2TP53 | |
| SCHEMBL18267902 | 0.94 | RAB9A (0.61) | RAB9ANR1I3NPC1SMN1; SMN2TP53 | |
| SCHEMBL4546931 | 0.94 | RAB9A (0.61) | RAB9ANR1I3NPC1SMN1; SMN2TP53 | |
| SCHEMBL15588093 | 0.94 | RAB9A (0.61) | RAB9ANR1I3NPC1SMN1; SMN2ENPP3 | |
| SCHEMBL4546973 | 0.94 | RAB9A (0.61) | RAB9ANR1I3NPC1SMN1; SMN2TP53 | |
| SCHEMBL4546951 | 0.93 | RAB9A (0.60) | RAB9ANR1I3NPC1SMN1; SMN2TP53 | |
| SCHEMBL20174195 | 0.92 | RAB9A (0.59) | RAB9ANR1I3NPC1SMN1; SMN2ENPP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8877355-B2 | Monoamine compound, charge-transporting material, and organic electroluminescent device | MITSUBISHI CHEMICAL CORPORATION (JP) | 2014-11-04 | — | — | US | disclosed |
| US-20130214263-A1 | MONOAMINE COMPOUND, CHARGE-TRANSPORTING MATERIAL, AND ORGANIC ELECTROLUMINESCENT DEVICE | MITSUBISHI CHEMICAL CORPORATION (JP) | 2013-08-22 | — | — | US | disclosed |
| US-8427046-B2 | Monoamine compound, charge-transporting material, and organic electroluminescent device | MITSUBISHI CHEMICAL CORPORATION (JP) | 2013-04-23 | — | — | US | disclosed |
| US-8178215-B2 | Organic compound containing at least two carbazolyl-substituted phenyl structures; charge-transporting material and organic el element containing the compound | PIONEER CORPORATION (JP) | 2012-05-15 | — | — | US | disclosed |
| US-20090236973-A1 | ORGANIC COMPOUND, CHARGE-TRANSPORTING MATERIAL, AND ORGANIC ELECTROLUMINESCENT ELEMENT | PIONEER CORPORATION (JO) | 2009-09-24 | — | — | US | disclosed |
| US-20090230846-A1 | MONOAMINE COMPOUND, CHARGE-TRANSPORTING MATERIAL, AND ORGANIC ELECTROLUMINESCENT DEVICE | MITSUBISHI CHEMICAL CORPORATION (JP) | 2009-09-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090236973-A1 | ORGANIC COMPOUND, CHARGE-TRANSPORTING MATERIAL, AND ORGANIC ELECTROLUMINESCENT ELEMENT | SLCO4C1, SLCO2A1, SLCO2B1 | RAB9A 1478/4885NR1I3 2288/4885NPC1 652/4885 |
| US-20090230846-A1 | MONOAMINE COMPOUND, CHARGE-TRANSPORTING MATERIAL, AND ORGANIC ELECTROLUMINESCENT DEVICE | SLC7A5, SLC18A1, MAOA | RAB9A 362/4885NR1I3 2164/4885NPC1 1424/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.